Literature DB >> 9233621

Identification of a STAT6 domain required for IL-4-induced activation of transcription.

B Lu1, M Reichel, D A Fisher, J F Smith, P Rothman.   

Abstract

Tyrosine phosphorylation of STAT6 in response to IL-4 results in the formation of STAT6 homodimers that bind specific DNA elements. Although binding sites for STAT6 have been shown to be important for the function of several IL-4-inducible promoters, the role of STAT6 in this activation has not been defined. To determine whether STAT6 is a transcriptional activator, different portions of the carboxyl terminus of STAT6 were fused to the yeast Gal4 protein DNA binding domain. Analysis of these chimeric Gal4-STAT6 proteins demonstrates that a 140-amino-acid proline-rich region of the carboxyl terminus of STAT6 contains a region that activates transcription. Truncation mutants of STAT6 that lack this domain cannot activate transcription and are capable of repressing transcription stimulated by a wild-type STAT6 protein. Strikingly, the ability of IL-4 to induce transcription from the Ig germline epsilon promoter is suppressed by overexpression of a carboxyl-terminal deletion mutant of STAT6. These studies demonstrate that the carboxyl terminus of STAT6 contains an activating domain required for the induction of genes by IL-4.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9233621

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Identification of two residues in MCM5 critical for the assembly of MCM complexes and Stat1-mediated transcription activation in response to IFN-gamma.

Authors:  C J DaFonseca; F Shu; J J Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

2.  The DNA replication factor MCM5 is essential for Stat1-mediated transcriptional activation.

Authors:  Marylynn Snyder; Wei He; J Jillian Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

3.  Histamine affects STAT6 phosphorylation via its effects on IL-4 secretion: role of H1 receptors in the regulation of IL-4 production.

Authors:  Geetanjali Kharmate; Zhongfeng Liu; Eric Patterson; Manzoor M Khan
Journal:  Int Immunopharmacol       Date:  2006-11-20       Impact factor: 4.932

4.  Targeted disruption of the interferon-gamma receptor 2 gene results in severe immune defects in mice.

Authors:  B Lu; C Ebensperger; Z Dembic; Y Wang; M Kvatyuk; T Lu; R L Coffman; S Pestka; P B Rothman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

5.  T-cell protein tyrosine phosphatase, distinctively expressed in activated-B-cell-like diffuse large B-cell lymphomas, is the nuclear phosphatase of STAT6.

Authors:  Xiaoqing Lu; Jun Chen; R Tedjo Sasmono; Eric D Hsi; Kristopher A Sarosiek; Tony Tiganis; Izidore S Lossos
Journal:  Mol Cell Biol       Date:  2007-01-08       Impact factor: 4.272

Review 6.  Transcriptional regulation by STAT6.

Authors:  Shreevrat Goenka; Mark H Kaplan
Journal:  Immunol Res       Date:  2011-05       Impact factor: 2.829

7.  Antiviral response in cells containing Stat1 with heterologous transactivation domains.

Authors:  Y Shen; J E Darnell
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

8.  Pim serine/threonine kinases regulate the stability of Socs-1 protein.

Authors:  X Peter Chen; Julie A Losman; Simone Cowan; Elizabeth Donahue; Scott Fay; Bao Q Vuong; Martijn C Nawijn; Danielle Capece; Victoria L Cohan; Paul Rothman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

9.  Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction.

Authors:  J A Losman; X P Chen; D Hilton; P Rothman
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

10.  STAT6 mediates interleukin-4 growth inhibition in human breast cancer cells.

Authors:  Jennifer L Gooch; Barbara Christy; Douglas Yee
Journal:  Neoplasia       Date:  2002 Jul-Aug       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.